Provided are compounds and compositions which modulate the level or activity of PIP4K2C. Also provided are methods for treating diseases or conditions by modulating (e.g., reducing) the level or activity of a PIP4K2C, comprising administering the compounds and compositions.
Provided are compounds and compositions which modulate the level or activity of PIP4K2C. Also provided are methods for treating diseases or conditions by modulating (e.g., reducing) the level or activity of a PIP4K2C, comprising administering the compounds and compositions.
Synthesis of <i>o</i>-Alkenylated 2-Arylbenzoxazoles via Rh-Catalyzed Oxidative Olefination of 2-Arylbenzoxazoles: Scope Investigation, Structural Features, and Mechanism Studies
protocols for direct regioselective functionalization of 2-arylbenzoxazoles are in high demand. Herein, we disclose a general method for selective ortho-olefination of 2-arylbenzo[d]oxazoles with alkenes enabled by versatile Cp*Rh(III) in high yields. This protocol features broad functional group tolerance and high regioselectivity. Intermolecular competition studies and kinetic isotope effect experiments imply
2-芳基苯并恶唑是有前途的分子,可在医学和材料领域得到潜在应用。对2-芳基苯并恶唑的直接区域选择性官能化的有效方案有很高的要求。在本文中,我们公开了通用的Cp * Rh(III)能够以高收率实现2-芳基苯并[ d ]恶唑与烯烃的选择性邻烯化的一般方法。该协议具有广泛的功能基团耐受性和高区域选择性。分子间竞争研究和动力学同位素效应实验表明,氧化烯化过程是通过亲电的C–H活化途径发生的。m的分子结构在间位F原子或杂原子取代基存在的情况下,氟取代的烯化产物可在受阻更强的位置证实区域选择性C–H活化/烯化。在单-和双-烯烃化产物的结构中观察到明显的扭转角,这导致烯烃质子的化学位移明显不同。另外,两个克级反应和进一步的转化实验表明,该方法对于合成邻链烯基化的2-芳基苯并恶唑衍生物是实用的。
Scyllo-inositol as a convenient protecting group for aryl boronic acids in Suzuki–Miyaura cross-coupling reactions
Herein, we report air- and water-stable borate complexes between scyllo-inositol and aryl boronic acids. The complexes were less reactive than free aryl boronic acids under Suzuki–Miyaura cross-coupling reaction conditions; thus, the borate complexes were used as protected boronic acids. Although protecting groups for organoboronicacids are useful in coupling reactions, especially those used to produce
Provided are compounds and compositions which modulate the level or activity of PIP4K2C. Also provided are methods for treating diseases or conditions by modulating (e.g., reducing) the level or activity of a PIP4K2C, comprising administering the compounds and compositions.